OmniAb's earnings call highlighted substantial progress in expanding partnerships and launching innovative technologies, notably OmniUltra and the xPloration program. However, financial challenges were evident with a decline in Q3 revenue and delayed milestones. Despite these setbacks, the company's strengthened financial position and strategic initiatives are promising.

Company Guidance

During OmniAb's third quarter 2025 financial results call, the company provided detailed guidance on several key metrics. They ended Q3 with 104 active partners, surpassing last year's program adds, and reported a total of 399 active programs, including a net addition of 36 programs year-to-date. Financially, OmniAb reported Q3 revenue of $2.2 million, down from $4.2 million the previous year, primarily due to a reduction in milestones and service revenue. Operating expenses decreased to $20.4 million from $23.9 million in Q3 2024. The company's cash balance as of September 30, 2025, was $59.5 million, bolstered by a $30 million private placement. OmniAb updated its 2025 revenue guidance to $18-$22 million and operating expenses to $82-$86 million. The company expects its cash balance to be between $52 million and $56 million by year-end.

Record Growth in Program Additions

The number of new program additions in Q3 2025 equaled the total number for all of 2024, indicating a significant uptick in new initiatives and partnerships.

Expansion of Active Partners

OmniAb reached a record high of over 100 active partners, showcasing the company's growing influence and successful partner engagement.

Successful Launch and Demand for xPloration

The xPloration partner access program is gaining strong traction, generating interest and new opportunities, and is expected to be accretive to earnings and cash flow.

OmnidAb-derived Program Enters Clinical Trials

The first OmnidAb-derived program entered human clinical trials, marking a significant milestone for the technology within a short timeframe since its launch.

Introduction of OmniUltra

OmniAb announced the launch of OmniUltra, the first transgenic chicken producing cow-like antibodies with ultra-long CDRH3s, opening new market opportunities.

Strengthened Financial Position

Closed a $30 million private placement in late August, enhancing financial flexibility and strengthening the balance sheet.

OmniAb (OABI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

OABI Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Mar 25, 2026	2025 (Q4)	-0.09 / -	-0.12	―	―	―
Nov 04, 2025	2025 (Q3)	-0.14 / -0.14	-0.16	12.50% (+0.02)
Aug 06, 2025	2025 (Q2)	-0.15 / -0.15	-0.13	-15.38% (-0.02)
May 08, 2025	2025 (Q1)	-0.16 / -0.17	-0.19	10.53% (+0.02)
Mar 18, 2025	2024 (Q4)	-0.11 / -0.12	-0.14	14.29% (+0.02)
Nov 12, 2024	2024 (Q3)	-0.14 / -0.16	-0.16	0.00% (0.00)
Aug 08, 2024	2024 (Q2)	-0.17 / -0.13	-0.15	13.33% (+0.02)
May 09, 2024	2024 (Q1)	-0.16 / -0.19	-0.06	-216.67% (-0.13)
Mar 20, 2024	2023 (Q4)	-0.14 / -0.14	0.07	-300.00% (-0.21)
Nov 09, 2023	2023 (Q3)	-0.14 / -0.16	-0.285	43.86% (+0.12)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

OABI Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 04, 2025	$1.48	$1.42	-4.05%
Aug 06, 2025	$1.93	$1.88	-2.59%
May 08, 2025	$1.57	$1.44	-8.28%
Mar 18, 2025	$3.19	$2.54	-20.38%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does OmniAb (OABI) report earnings?

OmniAb (OABI) is schdueled to report earning on Mar 25, 2026, TBA (Confirmed).

What is OmniAb (OABI) earnings time?

OmniAb (OABI) earnings time is at Mar 25, 2026, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is OABI EPS forecast?

OABI EPS forecast for the fiscal quarter 2025 (Q4) is -0.09.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing